These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 24630001

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M, Leux C, Fenot M, Célerier P, Maillard H.
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
    Brehmer F, Lockmann A, Grönemeyer LL, Kretschmer L, Schön MP, Thoms KM.
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J.
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
    Alvarez MA, Ruano J, Gómez FJ, Casas E, Baamonde C, Salvatierra A, Moreno JC.
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e282-8. PubMed ID: 22827710
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reply to: "Commenting on: Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis".
    Lecouflet M, Maillard H.
    J Am Acad Dermatol; 2015 Jan; 72(1):201. PubMed ID: 25497932
    [No Abstract] [Full Text] [Related]

  • 15. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P, Moraru E, Kittler H, Voller B, Kranz G, Auff E.
    Wien Klin Wochenschr; 2001 Jan; 113 Suppl 4():36-41. PubMed ID: 15506051
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Botulinum toxin A for palmar hyperhidrosis.
    Wollina U, Karamfilov T.
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):555-8. PubMed ID: 11843216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.